Conclusion
Halothane has been successfully used as a solvent for the liposome formulation of NSC-639829. Liposomes with similar morphology, particle size, incorporation efficiency, and stability were obtained with halothane, chloroform, and ether. Halothane provides additional ease in formulation because of its higher volatility and safety as compared with chloroform and ether. Halothane can be regarded as a safe alternative to chloroform or ether in liposome formulation.
Similar content being viewed by others
References
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238–252.
Massing U, Fuxius S. Liposome formulations of anticancer drugs: selectivity and effectiveness. Drug Resist Updat. 2000;3:171–177.
Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987;47:3039–3051.
Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissue. Microvasc Res. 1986;31:288–305.
Budavari S. The Merck Index. 12th ed. Whitehouse Station, NJ: Merck and Co; 1996.
Verschueren K. Environmental Data. Handbook of Environmental Data on Organic Chemicals. 2nd ed. New York, NY: Van Nostrand Reinhold; 1983: 178–179.
Ran Y, Yalkowsky SH. Halothane, a novel solvent for the preparation of liposomes containing 2-4′-amino-3′-methylphenyl benzothiazole (AMPB), an anticancer drug: a Technical Note. AAPS Pharm Sci Tech. 2003;4(2) article 20.
Sax NI, Lewis RJ Sr. General Chemicals: Entries A-E. Dangerous Properties of Industrial Materials. 7th ed. New York, NY: Van Nostrand Reinhold; 1989: 1634–1635.
Medical Economics. Physicians' Desk Reference. 41st ed. Oradell, NJ: Medical Economics Co; 2002.
Occupational Safety and Health Administration. Chemical Sampling Information. Washington, DC: US Department of Labor, 1999.
Okada H, Kato M, Koyanagi T, Mizuno K. Synthesis and antitumor activity of water-soluble benzoylphenylureas. Chem Pharm Bull. 1999;47(3):430–433.
Jain N, Yang G, Tabibi ES, Yalkowsky SH. Solubilization of NSC-639829. Int J Pharm. 2001;225:41–47.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jain, A., Sanghvi, T. & Yalkowsky, S.H. Liposome formulation of NSC-639829 using halothane as a solvent: A technical note. AAPS PharmSciTech 4, 52 (2003). https://doi.org/10.1208/pt040452
Received:
Accepted:
DOI: https://doi.org/10.1208/pt040452